 |
|
Picture of the Month
Karen M. Kreiling, MD;
Louis C. Hampers, MD;
Carl R. Baum, MD
From the Department of Pediatrics, Children's Memorial Hospital, Chicago, Ill.
Arch Pediatr Adolesc Med. 2000;154:1161-1162.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
TABLETS WERE NOTED in the vomitus of a 20-month-old girl. Unwitnessed, she had ingested a quantity of her grandmother's medication from a prescription container labeled "Procardia XL, 30 mg" (Pfizer Inc, New York, NY). Examination of the vomitus revealed 9 tablets and some activated charcoal (Figure 1). Concern arose because the tablets did not match the appearance of Procardia XL tablets (Figure 2). A Procardia XL tablet was obtained from an inpatient pharmacy and rinsed under water (Figure 3). Figure 4 is a schematic drawing of the nifedipine Gastrointestinal Therapeutic System (GITS).
| |
Figure 1.
|
|
| |
Figure 2.
|
|
| |
Figure 3.
|
|
| |
Figure 4.
|
|
Denouement and Discussion: Ingestion of Nifedipine Sustained-Release Tablets
Figure 1. Saliva and gastric fluid have dissolved the outer pink coating, revealing the bilayer brown and yellow appearance of the Gastrointestinal Therapeutic System.
Figure 2. Procardia XL 30-mg tablet . . . [Full Text of this Article]
|
